Targeting a non-oncogene addiction to the ATR/CHK1 axis for the treatment of small cell lung cancer-Reference-Cited by-同舟云学术

Targeting a non-oncogene addiction to the ATR/CHK1 axis for the treatment of small cell lung cancer

Published:2017-11-14 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Doerr Fabian,George Julie,Schmitt Anna,Beleggia Filippo,Rehkämper Tim,Hermann Sarah,Walter Vonn,Weber Jean-Philip,Thomas Roman K.,Wittersheim Maike,Büttner Reinhard,Persigehl Thorsten,Reinhardt H. Christian

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-15840-5.pdf

Reference60 articles.

1. Subramanian, J. & Govindan, R. Chemotherapy: continued lack of progress in SCLC. Nat Rev Clin Oncol 7, 77–78 (2010).

2. George, J. et al. Comprehensive genomic profiles of small cell lung cancer. Nature 524, 47–53 (2015).

3. Peifer, M. et al. Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat Genet 44, 1104–1110 (2012).

4. Fruh, M. et al. Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 24(Suppl 6), vi99–105 (2013).

5. Saunders, L. R. et al. A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo. Sci Transl Med 7, 302ra136 (2015).

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carrier-free cryptotanshinone-peptide conjugates self-assembled nanoparticles: An efficient and low-risk strategy for acne vulgaris;Asian Journal of Pharmaceutical Sciences;2024-08

2. Targeting DNA Damage Response Deficiency in Thoracic Cancers;Drugs;2024-07-13

3. Closing the RCT Gap—A Large Meta-Analysis on the Role of Surgery in Stage I–III Small Cell Lung Cancer Patients;Cancers;2024-05-30

4. Synthetic lethal combination of CHK1 and WEE1 inhibition for treatment of castration-resistant prostate cancer;Oncogene;2024-01-25

5. NFIB controls chemosensitivity in small cell lung cancer by suppressing Notch signaling activity;2024-01-17